1. Switzerland Stocks

  2. •

    Distribution services

  3. •

    Medical distributors
DKSH Holding Ltd

DKSH Holding Ltd

83.00
EUR
0.00
(0.00%)
4.39BMarket Cap
Feb 16Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
149.23
151.34
154.53
161.51
169.22
174.43
178.04
165.2
170.92
174.22
170.36
170.76
170.38
- -
Basic EPS, GAAP
3.57
2.96
3.11
3.21
3.18
3.92
2.65
2.42
3.45
3.09
2.8
3.31
3.12
- -
Free Cash Flow per Basic Share
2.99
2.9
2.93
1.98
2.14
2.16
3.72
4.45
5.2
3.65
5.25
4.95
4.34
- -
Dividend per Share
0.94
1.09
1.15
1.3
4.5
1.65
1.85
1.9
1.95
2.05
2.15
2.25
2.35
- -
Book Value per Share
19.85
22.28
23.2
25.24
24.24
26.3
27.28
26.73
27.84
27.07
25.97
28.02
27.02
26.33
Tangible Book Value per Share
17.69
19.84
21.2
23.32
22.05
24.29
22.69
22.19
21.76
14.37
13.88
15.41
14.69
13.8
Basic Weighted Avg Shares
64
65
65
65
65
65
65
65
65
65
65
65
65
65
Sales/Revenue/Turnover
9,559
9,818
10,051
10,505
11,006
11,345
11,579
10,742
11,106
11,320
11,066
11,094
11,071
- -
Operating Margin (%)
2.54
2.5
1.81
2.62
2.39
2.08
2.02
2.2
2.36
2.58
2.73
2.96
2.95
- -
Depreciation Expense
43
42
72
40
38
45
136
129
128
127
132
127
122
- -
Net Income, GAAP
229
192
203
209
207
255
173
157
224
201
182
215
203
- -
Effective Tax Rate (%)
22.16
26.64
27.23
27.35
26.57
21.48
25.29
26.07
24.53
27.08
28.15
29.47
28.73
- -
Profit Margin (%)
2.39
1.96
2.02
1.99
1.88
2.25
1.49
1.46
2.02
1.78
1.64
1.94
1.83
- -
Working Capital
1,063
1,177
1,276
1,400
1,275
1,483
1,440
1,388
1,239
1,288
1,150
1,086
1,233
1,145
LT Debt
50
29
76
57
23
83
371
362
322
791
692
545
683
659
Total Equity
1,315
1,490
1,540
1,678
1,634
1,769
1,835
1,800
1,886
1,826
1,738
1,880
1,821
1,773
Return on Invested Capital (%)
16.59
12.75
11.64
11.97
11.96
10.95
9.05
7.85
8.58
8.47
7.64
8.3
8.62
- -
Return on Capital (%)
15.75
12.8
12.97
12.2
11.69
14.01
8.8
7.07
9.67
8.04
7.29
8.55
8.1
- -
Return on Common Equity (%)
18.82
14.1
13.7
13.24
12.86
15.5
9.91
8.94
12.62
11.27
10.56
12.25
11.35
- -

Capital Structure

CHF

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
ST Debt
158
70
103
LT Borrowings
381
494
468
LT Finance Leases
198
189
191
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
65
65
65
Market Capitalization
- -
- -
4,051

Working Capital

CHF

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
Total Current Assets
4,019
4,131
4,160
Cash, Cash Equivalents & STI
482
538
504
Accounts Receivable, Net
1,779
2,148
1,830
Inventories
1,310
1,254
1,367
Total Current Liabilities
2,993
2,898
3,016
Payables & Accruals
- -
- -
- -
ST Debt
158
70
103
Deferred Revenue
- -
- -
- -

Growth Rates

CHF

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
1.83%
0.37%
-3.13%
Free Cash Flow
8.11%
2.54%
-12.26%
Net Income, GAAP
1.94%
7.06%
-5.54%
Sales/Revenue/Turnover
1.03%
0.62%
-0.21%
Total Cash Common Dividend
23.21%
4.31%
4.45%

Semi-annual Revenue

CHF

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
11,094
2025
- -
- -
11,071
2026
- -
- -
- -

Semi-annual Earnings Per Share

CHF

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
3.31
2025
- -
- -
3.12
2026
- -
- -
- -

Semi-annual Dividends Per Share

CHF

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
2.25
2025
- -
- -
2.35
2026
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Stefan P. Butz
Full Time Employees
24,799
Sector
Distribution services
Industry
Medical distributors
Address
Wiesenstrasse 8 Zurich ZH Switzerland 8034
IPO Date
Mar 21, 2012
Website
dksh.com
Similar Companies
DataMeds AI, Inc. (NASDAQ:MEDS)
Selcuk Ecza Deposu Ticaret ve Sanayi A.S. (BIST:SELEC)
McKesson Corporation (NYSE:MCK)
Ibnsina Pharma (EGX:ISPH)
Cardinal Health, Inc. (NYSE:CAH)
Entero Healthcare Solutions Limited (NSE:ENTERO)
Business
DKSH Holding AG (DKSH.SW) is a leading provider of market expansion services that offers integrated solutions including sourcing, marketing, sales, distribution, e-commerce, logistics and after-sales services across Asia Pacific, Europe and North America. The company operates through four main business units: Consumer Goods, focused on fast-moving consumer goods, luxury and lifestyle products including beauty, sports nutrition and food services; Healthcare, encompassing pharmaceuticals, consumer health, over-the-counter products, medical devices and patient support services; Performance Materials, supplying specialty chemicals, ingredients and raw materials to the chemical, pharmaceutical, food, beverage and personal care industries; and Technology, providing advanced machinery, analytical and scientific instruments, components and consumables for industry and construction. Founded in 1865 through the merger of Swiss trading houses and headquartered in Zurich, Switzerland, DKSH employs over 29,000 specialists and serves more than 150,000 clients in 36 markets, with a primary focus on Asia Pacific. In recent developments, DKSH has pursued an aggressive acquisition strategy, including the 2025 purchase of Partizan Worldwide in Australia to bolster patient services in Healthcare, CS&Co in New Zealand for beauty distribution in Consumer Goods, Georg Breuer GmbH in Germany for food ingredients in Performance Materials, Aston Chemicals in the UK to expand personal care offerings, and Eppendorf's direct business in Thailand for Technology; it also formed a strategic partnership with Bayer for pharmaceutical services in Southeast Asia and continues market consolidation through deals like DNIV Group in Asia for semiconductors.

Company News

Company News APIChatGPT